IgG2 from Myeloma Plasma

<strong>IgG2 from Myeloma Plasma</strong>_x000D_ <strong>Catalog number:</strong> B2016900_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -80°C_x000D_ <strong>Keywords:</strong> Native Human IgG2 Myeloma Plasma_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Wypych J, Li M, Guo A, Zhang Z, Martinez T, Allen MJ, Fodor S, Kelner DN, Flynn GC, Liu YD, Bondarenko PV, Ricci MS, Dillon TM, Balland A. Human IgG2 antibodies display disulfide-mediated structural isoforms J Biol Chem. 2008 Jun 6;283(23):16194-205._x000D_ 2: Thürmann P, Harder S. Criteria for the appropriate drug utilisation of immunoglobulin Pharmacoeconomics. 1996 May;9(5):417-29._x000D_ 3: Holvoet P, Stassen JM, Hashimoto Y, Spriggs D, Devos P, Collen D. Binding properties of monoclonal antibodies against human fragment D-dimer of cross-linked fibrin to human plasma clots in an in vivo model in rabbits Thromb Haemost. 1989 Apr 25;61(2):307-13._x000D_ 4: Thürmann PA, Sonnenburg C, Valentová K, Gregora E, Freischläger F, Lissner R. Pharmacokinetics of viral antibodies after administration of intravenous immunoglobulin in patients with chronic lymphocytic leukaemia or multiple myeloma Eur J Clin Pharmacol. 2001 Jun;57(3):235-41._x000D_ 5: Grosicki S, Bednarczyk M, Kociszewska K. Elranatamab: a new promising BispAb in multiple myeloma treatment Expert Rev Anticancer Ther. 2023 Jul-Dec;23(8):775-782._x000D_ 6: Ito A, Yamauchi T, Nakano A, Fujino M, Ito M. IgG4 plasma cell myeloma: Clinicopathological characteristics and diagnosis Pathol Int. 2020 Aug;70(8):551-556._x000D_ 7: Abramson N, Shattil SJ. M-components JAMA. 1973 Jan 8;223(2):156-9._x000D_ 8: Osserman EF, Merlini G, Butler VP Jr. Multiple myeloma and related plasma cell dyscrasias JAMA. 1987 Nov 27;258(20):2930-7._x000D_ 9: Mellstedt H, Hammarström S, Holm G. Monoclonal lymphocyte population in human plasma cell myeloma Clin Exp Immunol. 1974 Jul;17(3):371-84._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/36550523">10: Aloui M, Ben Rejeb S, Boudokhan M, Dhaoui A, Ben Romdhane M, Belakhal S. Bone metastatic carcinoma coexisting with plasma cell myeloma: a case report J Med Case Rep. 2022 Dec 23;16(1):477. </a>_x000D_ _x000D_ <strong>Products Related to IgG2 from Myeloma Plasma can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>